Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 8Fibrosis 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Mucositis 2Lymphedema 2Erectile Dysfunction 2Sarcoidosis, Pulmonary 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pentoxifylline, Cisplatin, Nephrotoxixcity 1Pancreatitis, Alcoholic 1Pancreatitis 1Pain 1Osteoradionecrosis 1Non-small Cell Lung Cancers 1Neuritis 1Neoplasms 1Long-term Adverse Effects of Radiotherapy for Pelvic Cancer 1Hodgkin Disease 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Capsular Contractures 1

Interventions

Docetaxel 277Prednisone 236enzalutamide 175Leuprolide 172Radiotherapy 164Abiraterone Acetate 153Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 78abiraterone 75gallium 68 PSMA-11 74Specimen Handling 67Gonadotropin-Releasing Hormone 58darolutamide 56Radiation 56Triptorelin Pamoate 53cabazitaxel 49Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Pentoxifylline × Clear all
NCT03406169 2018-01-23

Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy

Brooke Army Medical Center

Phase 3 Unknown
180 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡